Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Clinical trial NCT02473224 · COMPLETED
Trial details
- NCT number
- NCT02473224
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2018-11-27
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.